Stannin (SNN) is a highly conserved protein localized to chromosome 16 in humans 1 that plays a critical role in cellular responses to organometallic toxins and intracellular trafficking. The primary function of SNN involves mediating the toxic effects of organotins, particularly trimethyltin, in sensitive cell populations 2. Additionally, SNN participates in endosomal maturation, a key step in the endocytic pathway essential for proper membrane trafficking and cellular homeostasis 3. At the molecular level, SNN functions through metal ion binding and cytoplasmic/membrane localization, positioning it as a direct responder to toxic metal exposure. The gene exhibits an unusual cell-specific expression pattern regulated by multiple promoter elements and transcription factor-binding sites, suggesting tissue-dependent regulation 1. Clinically, SNN's relevance to neurological disease remains understudied based on available evidence, though its role in organotin toxicity is significant given the historical use of these compounds in industrial and agricultural applications. The high evolutionary conservation between rodent and human sequences (98% identity) indicates functional importance across species. Further investigation into SNN's contribution to metal-induced neurodegeneration and its therapeutic targeting may reveal additional clinical significance beyond established organometal toxicology.